+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2020

  • ID: 4856022
  • Report
  • November 2019
  • Region: Global
  • 200 pages
  • The Business Research Company
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Astellas Pharma Inc.
  • Coloplast A/S
  • Karl Storz
  • Medifocus Inc. (Canada)
  • NxThera
  • Prostalund Operations AB
  • MORE
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Global Report 2020 from the author provides strategists, marketers and senior management with the critical information they need to assess the global benign prostatic hyperplasia (BPH) treatment devices and equipment market.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the benign prostatic hyperplasia (BPH) treatment devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Global Report from the author answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market
  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
Scope
  • Markets Covered: 1) By Product: Resectoscopes, Radiofrequency ablation device, Urology lasers, Prostatic Stents, Implants 2) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home 3) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection of Prostate (TURP), Transurethral Incision of Prostate (TUIP), Transurethral microwave thermotherapy (TUMT), Laser surgery Others
  • Companies Mentioned: Karl Storz, Lumenis, Olympus, Urologix, Boston scientific Inc.
  • Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time Series: Five years historic and forecast.
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Astellas Pharma Inc.
  • Coloplast A/S
  • Karl Storz
  • Medifocus Inc. (Canada)
  • NxThera
  • Prostalund Operations AB
  • MORE
1. Executive Summary

2. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Characteristics

3. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Size And Growth
3.1. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Segmentation
4.1. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Resectoscopes Radiofrequency ablation device
  • Urology lasers Prostatic Stents
  • Implants
4.2. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Hospitals Ambulatory Surgical Centres (ASC)
  • Clinics Home
4.3. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Transurethral Needle Ablation (TUNA) Transurethral Resection of Prostate (TURP)
  • Transurethral Incision of Prostate (TUIP) Transurethral microwave thermotherapy (TUMT)
  • Laser surgery Others
5. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Regional And Country Analysis
5.1. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
6.1. Asia-Pacific Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
6.2. Asia-Pacific Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
7.1. China Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
7.2. China Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
8.1. India Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
8.2. India Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
9.1. Japan Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
9.2. Japan Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
10.1. Australia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
11.1. Indonesia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
12.1. South Korea Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
13.1. Western Europe Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
13.2. Western Europe Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
14.1. UK Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
14.2. UK Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
15.1. Germany Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
16.4. France Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.5. France Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
17.1. Eastern Europe Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
17.2. Eastern Europe Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
18.1. Russia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
19.1. North America Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
19.2. North America Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
20.1. USA Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
20.2. USA Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
21.1. South America Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
21.2. South America Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
22.1. Brazil Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
23.1. Middle East Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
23.2. Middle East Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
24.1. Africa Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Overview
24.2. Africa Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Competitive Landscape And Company Profiles
25.1. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Competitive Landscape
25.2. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Company Profiles
25.2.1. Karl Storz
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Lumenis
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Olympus
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Urologix
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Boston scientific Inc.
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Benign Prostatic Hyperplasia Treatment Devices and Equipment Market

27. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Trends And Strategies

28. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Future Outlook and Potential Analysis

29. Appendix
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Astellas Pharma Inc.
  • Coloplast A/S
  • Karl Storz
  • Medifocus Inc. (Canada)
  • NxThera
  • Prostalund Operations AB
  • MORE
The benign prostatic hyperplasia (BPH) treatment devices and equipment market consists of sales of benign prostatic hyperplasia (BPH) treatment devices and equipment and related services. Benign prostatic hyperplasia or benign prostatic hypertrophy is a condition of an enlarged prostate gland which causes blockade of urethra, the tube that carries urine from the bladder. The market is segmented into resectoscopes, radiofrequency ablation device, urology lasers, prostatic stents and implants.

The global benign prostatic hyperplasia (BPH) treatment devices and equipment market was valued at about $0.9 billion in 2018 and is expected to grow to $1.13 billion at a CAGR of 5.9% through 2022.

Benign Prostatic Hyperplasia (BPH) also called Prostate Gland Enlargement (PGE), is a condition where patient suffers from uncomfortable urinary symptoms. Due to rising prevalence of Benign Prostatic Hyperplasia (BPH), demand for the BPH treatment devices and equipment's is on a steady rise as the number of BPH cases increases the demand for devices will also increase. For example, in the USA by 2018, more than 8 million men are suffering from Benign Prostatic Hyperplasia (BPH) and globally around 22 million men have been diagnosed with moderate to severe symptoms of BPH. Therefore, with number of BPH cases on the steady rise, the demand for BPH treatment devices and equipment is also expected to grow.

The side effects suffered by the patients after a BPH procedure is one of the major restraints for BPH device and equipment market. For example, most common side effects of a BPH surgery includes, urinary incontinence, discomfort during urination and difficulty in completely emptying the bladder. The patients suffering from BPH does not prefer surgical procedures (till the stage it can be avoided) due to these side effects, therefore decreasing the demand of surgical procedures, which in turn limits the demand for devices used by end users like hospitals, clinics and ambulatory surgical centers.

Prostatic Astery Embolization (PAE) is one of the latest developments in the market for Benign Prostatic Hyperplasia (BPH) treatment device and equipment. PAE is a minimally invasive treatment that assists in reducing the symptoms observed in urinary tract. The PAE procedure is done using X-rays and other advanced imaging to observe the tumor inside the body and accordingly treat it without any surgery. This technique results in reduced complication in the treatment of BPH and thus is said to be a major development in the market of BPH treatment. Leading companies such as Boston scientifics, UNC healthcare, and Spire healthcare have been investing in the market for PAE.

Product recall is a process of retrieving all faulty and defective products that have been sold or are available in the market. When a company recalls a product from the market, the company bears all the cost of fixing the defective product and cost of replacement. This cost of replacement for large companies can go up to multi-million dollar, hence restraining the growth of the company and for the whole market as well. Product recall is one of the major hurdles for any market, Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment market is no exception. For example, in the year 2019, Procept BioRobotics Corporation recalled its AquaBeam Handpiece, a part of its AquaBeam Robotic System due to the possibility of developments of internal leak because of micro-cracks in specific weld joints within the product device. Also, in the year 2017, NXTHERA recalled its products like Rezum Systems and Vapor BPH Ablation System as the Needle Bond was not able to withstand the force when the needle was injected into and retracted from the prostate tissue in the treatment.

In 2018, Boston Scientific acquired NxThera for an upfront cash payment of $306 million, and up to an additional $100 million in potential commercial milestone payments over the next four years. This acquisition will strengthen Boston’s already existing urology and pelvic health portfolio range. The acquisition of NxThera would be the best fit along with Boston Scientific’s laser therapy systems for the treatment of symptomatic BPH such as the Greenlight XPSTM Laser Therapy system and holmium platforms. NxThera, Inc. is involved in the manufacturing of medical devices to treat patients suffering from urologic conditions such as benign prostatic hyperplasia (BPH), prostate cancer, and kidney cancer. It was founded in 2008 and is headquartered in Minnesota, USA.

Major players in the market are Karl Storz, Lumenis, Olympus, Urologix and Boston scientific Inc.
Note: Product cover images may vary from those shown
4 of 5
  • Karl Storz
  • Lumenis
  • Olympus
  • Urologix
  • Boston scientific Inc.
  • Endo International
  • Neo tract
  • Lisa Laser (U.S.)
  • Medifocus Inc. (Canada)
  • ProArc Medical LTD. (Israel)
  • Olympus America
  • Teleflex
  • Medtronic
  • Urotech
  • Prostalund Operations AB
  • Baxter International
  • NxThera
  • Richard Wolf GmbH
  • Coloplast A/S
  • Siemens
  • Quest Pharmatech
  • Protox Therapeutics
  • IntelGenx Technologies Corp
  • Astellas Pharma Inc.
  • Ipsen S.A.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll